Loading
A phase 3 trial of Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone, Etoposide, Mitoxantrone, Prednisone and Vincristine in Leukaemia, run by St. Jude Children's Research Hospital, completed.
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia is a phase 3 interventional study registered as NCT00136084 by St. Jude Children's Research Hospital, with 238 participants recorded, started 2002-08 and reaching its primary completion in 2008-07. Interventions recorded: Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone, Etoposide, Cytarabine, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate, Mitoxantrone, Prednisone, Vincristine. Conditions recorded: Leukemia, Myelocytic, Acute.
Linked to the drug Cladribine because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Shares Daunorubicin, Cytarabine, Prednisone, Dexamethasone and the tag pipeline.
Shares Daunorubicin, Cytarabine, Prednisone, Dexamethasone and the tag pipeline.
Shares Cladribine, Mitoxantrone, Daunorubicin and the tag pipeline.
Shares Cytarabine, Prednisone, Dexamethasone, Vincristine and the tag pipeline.
Shares Mitoxantrone, Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
Shares Daunorubicin, Cytarabine, Prednisone, Dexamethasone and the tag pipeline.
Shares Mitoxantrone, Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
Shares Mitoxantrone, Daunorubicin, Cytarabine, Etoposide and the tag pipeline.